protein
phosphatas
catalyz
half
phosphoserinethreonin
dephosphoryl
reaction
mammalian
cell
vivo
exist
free
catalyt
subunit
alway
associ
least
one
regulatori
protein
pip
gener
larg
set
distinct
holoenzym
complex
control
dephosphoryl
small
subset
substrat
screen
literatur
genet
engin
mous
model
identifi
model
isoform
pip
least
pip
connect
human
diseaseassoci
phenotyp
addit
phenotyp
relat
pip
clearli
link
alter
function
inform
lack
pip
propos
structur
revers
genet
combin
structur
character
protein
mous
genet
identifi
new
therapeut
target
avail
mous
model
confirm
pleiotrop
action
health
diseas
typic
mammalian
cell
threequart
protein
phosphoryl
serin
threonin
andor
tyrosin
residu
lifetim
phosphoryl
residu
ie
transfer
atp
hydroxyl
group
side
chain
catalyz
protein
kinas
protein
phosphatas
catalyz
hydrolyt
remov
phosphat
group
thu
spatiotempor
phosphoryl
state
protein
result
balanc
counteract
protein
kinas
protein
phosphatas
disturb
balanc
caus
aberr
phosphoryl
implic
variou
human
diseas
includ
cancer
cardiac
hypertrophi
diabet
neurodegener
therapeut
strategi
protein
phosphoryl
diseas
mainli
focus
drug
target
protein
kinas
although
protein
phosphatas
equal
attract
target
date
two
dozen
smallmolecul
protein
kinas
inhibitor
six
therapeut
antibodi
protein
tyrosin
kinas
approv
us
food
drug
administr
fda
clinic
use
mainli
target
cancer
therapi
along
fdaapprov
drug
hundr
protein
kinas
inhibitor
test
clinic
trial
contrast
protein
phosphatas
neglect
potenti
drug
target
classifi
undrugg
evok
misconcept
imposs
target
particular
protein
phosphatas
fact
multipl
studi
variou
research
group
reveal
protein
phosphatas
unequivoc
druggabl
target
variou
smallmolecul
effector
modul
activ
inhibit
protein
phosphatas
activ
exhibit
therapeut
potenti
variou
human
diseas
gener
exampl
immunosuppress
cyclosporin
success
use
treat
acut
organ
transplant
reject
rheumatoid
arthriti
psoriasi
crohn
diseas
target
inhibit
protein
serinethreonin
phosphatas
also
known
calcineurin
mode
action
howev
elucid
approv
us
fda
inhibitor
block
activ
site
bind
block
one
substrat
bind
site
variou
protein
tyrosin
phosphatas
ptp
inhibitor
includ
distinct
small
molecul
inhibitor
orthoster
bind
enzym
activ
site
alloster
bind
outsid
enzym
activ
site
competit
bind
enzym
site
substrat
bind
inhibitor
biolog
also
develop
therapeut
purpos
current
undergo
clinic
trial
exampl
smallmolecul
inhibitor
vascular
endotheli
ptp
test
treatment
diabet
macular
edema
metastat
breast
cancer
respect
protein
phosphatas
wide
express
highli
conserv
phosphatas
kda
activ
toward
phosphoserinethreonin
residu
belong
phosphoprotein
phosphatas
ppp
famili
eukaryot
protein
phosphatom
base
biochem
data
estim
respons
half
phosphoserinethreonin
dephosphoryl
reaction
eukaryot
cell
show
rather
broad
substrat
specif
vitro
exhibit
cellular
context
much
narrow
tightli
regul
substrat
select
mainli
achiev
associ
wide
array
protein
pip
therebi
form
distinct
multisubunit
pip
complex
dephosphoryl
small
subset
substrat
consist
numer
substrat
key
regul
sever
cellular
process
includ
cell
cycl
progress
protein
synthesi
premrna
splice
transcript
therefor
surpris
play
crucial
role
human
patholog
cancer
heart
diseas
memori
loss
type
diabet
viral
infect
suggest
great
therapeut
potenti
drug
genet
engin
mous
model
significantli
contribut
understand
physiolog
role
holoenzym
health
diseas
determin
vivo
gene
function
identifi
diseasecaus
target
gene
also
mous
model
often
crucial
discov
therapeut
target
demonstr
histori
develop
ptptarget
drug
first
breakthrough
discoveri
phenotyp
mice
global
delet
protein
tyrosin
phosphatas
mice
hypersensit
insulin
resist
obes
academ
pharmaceut
compani
began
search
inhibitor
treat
type
diabet
obes
review
first
summar
current
knowledg
structur
divers
holoenzym
way
specif
achiev
next
address
genet
modifi
mous
model
isoform
pip
sinc
pip
multifunct
andor
interact
multipl
protein
focu
mous
model
pip
phenotyp
connect
holoenzym
function
review
discoveri
made
mous
model
regard
vivo
function
holoenzym
therapeut
potenti
final
examin
mous
model
phenotyp
associ
human
diseas
abbrevi
protein
name
mous
genet
nomenclatur
defin
box
respect
holoenzym
consist
catalyt
subunit
one
two
regulatori
pip
fig
mammalian
genom
contain
three
gene
pipencod
gene
identifi
estim
hundr
yet
discov
mammalian
isoform
ident
amino
acid
level
wherea
pip
mainli
structur
unrel
protein
defin
holoenzym
activ
toward
set
substrat
bind
pip
facilit
short
linear
motif
slim
residu
long
bind
specif
surfac
groov
condit
genotyp
genotyp
depend
presenc
certain
factor
term
often
refer
cremedi
excis
genom
sequenc
flank
loxp
site
cre
recombinas
sitespecif
recombin
enzym
recogn
pair
long
dna
sequenc
known
loxp
site
creloxp
system
transgen
technolog
base
abil
cre
recombinas
excis
dna
sequenc
two
loxp
site
promot
creexpress
transgen
determin
spatiotempor
express
cre
recombinas
cre
recombinas
express
widespread
tissuespecif
andor
celltyp
specif
genotyp
descript
genet
inform
carri
organ
also
refer
specif
allel
variant
genet
engin
mice
mice
alter
genom
compar
wildtyp
mice
includ
knockout
knockin
transgen
mice
knockout
ko
casual
term
target
disrupt
gene
interest
lossoffunct
allel
produc
ko
creat
delet
portion
gene
make
nonfunct
replac
gene
alter
sequenc
creation
ko
involv
direct
homolog
recombin
ko
consid
transgen
knockin
ki
casual
term
target
mutat
gene
interest
alter
gene
function
lossoffunct
allel
produc
creation
ki
involv
direct
homolog
recombin
ki
consid
transgen
phenotyp
measur
observ
characterist
mice
result
interact
genet
background
environ
transgen
mice
mice
carri
transgen
genom
transgen
tg
dna
sequenc
introduc
germ
line
mice
random
integr
exampl
tg
transgen
express
driven
promot
fig
structur
holoenzym
surfac
represent
catalyt
domain
center
indic
two
metal
activ
site
red
sphere
lie
yshape
intersect
three
substratebind
groov
acid
groov
ctermin
groov
c
hydrophob
groov
h
inhibitori
pip
ipip
depict
yellow
guid
pip
gpip
blue
substrat
purpl
variou
interact
site
consid
therapeut
target
repres
color
circl
indic
inset
box
bend
black
arrow
indic
dephosphoryl
substrat
surfac
structur
made
use
pymol
wwwpymolcom
pip
substrat
schemat
place
protein
phosphatas
pip
protein
see
text
refer
multipl
slim
also
known
dock
motif
often
cluster
form
intrins
disord
domain
combin
bind
slim
establish
highaffin
bind
pip
often
associ
partial
structur
fold
domain
beststudi
motif
pip
interact
socal
rvxfmotif
dock
hydrophob
groov
remot
catalyt
pocket
fig
motif
present
known
pip
mutat
valin
andor
phenylalanin
alanin
often
suffici
least
partial
disrupt
interact
howev
slim
silkmotif
present
far
fewer
pip
addit
bind
site
highli
structur
leucinerich
repeat
ankyrin
repeat
date
dozen
distinct
site
character
enabl
huge
combinatori
potenti
gener
uniqu
holoenzym
number
combin
site
differ
holoenzym
confirm
sever
crystal
structur
explain
interact
numer
structur
unrel
pip
therapeut
viewpoint
promis
approach
develop
drug
involv
interfer
catalyt
site
specif
interact
site
within
holoenzym
drug
bind
catalyt
site
nonselect
target
holoenzym
possibl
even
structur
relat
phosphatas
holoenzym
contrast
drug
disturb
specif
holoenzym
select
modul
activ
toward
limit
number
substrat
divers
specif
pip
complex
show
extrem
phylogenet
function
conserv
even
though
number
gene
differ
speci
eg
gene
plant
gene
cerevisia
gene
melanogast
gene
vertebr
function
conserv
illustr
sequenc
ident
yeast
human
observ
lethal
loss
cerevisia
rescu
human
isoform
togeth
three
mammalian
gene
encod
four
nearli
ident
isoform
differ
primarili
extrem
isoform
aris
altern
splice
transcript
differ
term
retent
delet
last
intron
gene
result
isoform
uniqu
ctermin
tail
amino
acid
mice
respect
biochem
level
substanti
differ
isoform
genet
ablat
individu
gene
mice
suggest
distinct
overlap
function
discuss
section
tabl
gener
pip
structur
unrel
share
combin
variou
function
domain
involv
substraterecruit
andor
subcellulartarget
first
pip
contain
domain
discuss
section
fig
second
pip
addit
domain
cover
activ
site
therebi
prevent
substrat
bind
catalyt
site
domain
bind
activ
site
constitut
phosphoryl
third
mani
pip
specif
target
domain
mediat
bind
particular
subcellular
compart
structur
eg
sarcoplasm
reticulum
glycogen
particl
enhanc
local
concentr
promot
dephosphoryl
phosphosubstr
specif
associ
subcellular
structur
fourth
pip
contain
bind
domain
small
subset
substrat
combin
pip
substratebind
site
dramat
increas
affin
substrat
allow
dephosphoryl
physiolog
level
fifth
pip
prevent
dephosphoryl
certain
substrat
occlud
one
substratebind
groov
final
note
pip
often
combin
differ
strategi
multipl
pip
serv
substrat
associ
list
biochem
valid
pip
found
genet
modifi
mous
model
distinct
pip
often
multipl
model
one
pip
bring
total
number
mous
model
sinc
pip
multifunct
andor
interact
multipl
protein
critic
develop
potenti
drug
examin
whether
observ
phenotyp
depend
associ
therefor
screen
mous
model
identifi
phenotyp
connect
alter
function
determin
chang
activ
alter
phosphoryl
level
substrat
andor
phenotyp
associ
express
dysfunct
mutant
pip
base
criteria
select
mous
model
link
distinct
pip
tabl
function
classifi
pip
inhibitori
pip
ipip
guid
pip
gpip
fig
ipip
block
dephosphoryl
substrat
occupi
activ
site
thu
ablat
ipip
mice
lead
increas
dephosphoryl
physiolog
substrat
ipip
holoenzym
contrast
gpip
defin
pip
guid
toward
specif
subset
substrat
within
cell
ablat
gpip
mice
lead
increas
phosphoryl
vivo
substrat
gpip
complex
analyz
genet
alter
mous
model
ipip
gpip
describ
tabl
respect
global
ablat
isoform
mice
caus
overt
phenotyp
except
male
knockout
ko
mice
infertil
due
impair
spermiogenesi
tabl
agnu
nairn
person
commun
indic
isoform
compens
loss
tissu
except
testi
could
explain
distinct
express
pattern
isoform
testi
specif
express
somat
testicular
cell
spermatogonia
convers
post
meiotic
germ
cell
detect
thu
germcel
specif
delet
gene
result
male
infertil
sperm
abnorm
morpholog
teratospermia
due
loss
entir
cellular
pool
post
meiotic
germ
cell
tabl
accordingli
testisspecif
transgen
express
restor
fertil
null
mice
two
independ
mous
model
tabl
togeth
variou
mous
model
demonstr
uniqu
spermiogen
function
along
testisenrich
isoform
testi
spermenrich
pip
isoform
also
known
account
format
uniqu
pip
complex
testi
sperm
complex
attract
candidatetarget
pharmacolog
intervent
combat
male
infertil
sinc
drug
like
affect
cellular
process
tissu
contrast
total
ko
mice
global
delet
led
prewean
mortal
ie
homozygot
die
age
week
describ
intern
mous
phenotyp
consortium
tabl
lethal
phenotyp
suggest
essenti
function
compens
remain
isoform
like
exist
select
pip
exampl
ankyrin
domain
specif
interact
ctermin
domain
howev
biochem
data
chimera
reveal
central
ntermin
part
also
contribut
isoformspecif
function
select
delet
individu
isoform
heart
intern
mous
phenotyp
consortium
produc
ko
mice
phenotyp
accord
fulli
valid
standard
protocol
confirm
exist
function
specif
cardiacspecif
delet
either
embryon
adultheart
specif
cremedi
gene
delet
reveal
major
heart
phenotyp
ablat
isoform
use
condit
crelox
target
approach
induc
heart
failur
tabl
heartspecif
delet
associ
increas
myofila
phosphoryl
myosin
light
chain
cardiac
myosin
bind
protein
c
howev
caus
chang
phosphoryl
phospholamban
pln
key
regul
cardiac
contractil
hint
redund
isoform
dephosphoryl
pln
accordingli
heartspecif
overexpress
result
diminish
phosphoryl
pln
serin
phenotyp
transgen
mice
overexpress
also
show
reduc
heart
function
indic
neg
regul
cardiac
function
tabl
align
variou
studi
indic
increas
activ
associ
human
experiment
heart
failur
review
increas
activ
due
increas
level
andor
decreas
express
inhibitori
protein
associ
less
pln
phosphoryl
serin
threonin
collect
mous
model
isoform
reveal
function
overlap
uniqu
function
testi
multipl
tissu
includ
heart
variou
ipip
includ
inhibitor
homolog
dopamin
cyclic
ampregul
phosphoprotein
mr
inhibitor
ckinas
potenti
protein
inhibitor
r
kda
homolog
phosphoprotein
holoenzym
kinas
cenhanc
inhibitor
kepi
gut
brain
phosphatas
inhibitor
contain
region
schemat
represent
domain
structur
inhibitori
pip
ipip
guid
pip
gpip
gm
mu
musculu
depict
scale
contain
domain
red
box
domain
yellow
box
ntermin
third
inhibit
potent
phosphoryl
domain
threonin
residu
gm
contain
ntermin
glycogentarget
domain
second
subcellular
target
domain
bind
sarcoplasm
reticulum
sr
locat
cterminu
dopamin
cyclic
ampregul
phosphoprotein
kda
gm
skelet
muscl
glycogen
target
protein
phosphatas
regulatori
subunit
pip
protein
see
text
refer
hand
inhibitori
without
prior
phosphoryl
ipip
form
stabl
complex
alon
also
form
stabl
trimer
complex
variou
heterodimer
pip
fig
variou
trimer
complex
contain
describ
includ
spinophilin
neurabin
contrast
homolog
specif
inhibit
contain
complex
addit
wellknown
inhibitor
also
classifi
heat
shock
protein
ipip
base
report
vivo
inhibitori
function
genet
engin
mous
model
select
ipip
disclos
import
heart
brain
function
respons
viral
infect
tabl
suggest
holoenzym
associ
ipip
may
serv
therapeut
target
neurolog
psychiatr
disord
heart
diseas
viral
infect
describ
activ
enhanc
cardiac
function
long
term
protect
pressureoverloadinduc
hypertrophi
induc
heartspecif
tg
ko
improv
cardiac
contractil
young
mice
lethal
catecholaminerg
stress
age
heartspecif
tg
bind
mutant
cardiacspecif
tg
tg
activ
pnl
improv
cardiac
function
recoveri
reduc
infarct
improv
angiogenesi
diabet
heart
ac
acetyl
calciumcalmodulindepend
protein
kinas
type
ii
subunit
alpha
protein
kinas
cpotenti
protein
inhibitor
r
kda
camp
respons
elementbind
protein
dopamin
cyclic
ampregul
phosphoprotein
mr
dopamin
receptor
dopamin
receptor
extracellular
signalregul
kinas
gut
brain
phosphatas
inhibitor
glutam
ionotrop
receptor
nmda
type
subunit
glutam
ionotrop
receptor
ampa
type
subunit
histon
heterozyg
ho
halberomozyg
heat
shock
protein
kepi
kinas
cenhanc
inhibitor
ko
knockout
cardiac
muscl
isoform
myosin
heavi
chain
nd
determin
p
phospho
pln
cardiac
phospholamban
ribosom
protein
ryanodin
receptor
rtta
revers
tetracyclinecontrol
transactiv
sar
sever
acut
respiratori
syndrom
teto
tetracyclin
oper
tg
transgen
tta
tetracyclinecontrol
transactiv
ldopa
psychotomimet
druginduc
phorbol
esterinduc
ldopainduc
morphininduc
number
phosphoamino
acid
correspond
mous
sequenc
accord
http
wwwphosphositeorg
variou
mous
model
ipip
support
notion
inhibit
heart
attract
therapeut
approach
treat
heart
failur
cardiac
arrhythmia
tabl
first
global
ko
result
impair
heart
function
second
cardiacspecif
express
phosphomimet
mutant
act
constitut
activ
inhibitor
associ
decreas
activ
increas
phosphoryl
pln
serin
threonin
enhanc
heart
function
addit
express
mice
prevent
cardiac
dysfunct
hypertrophi
transvers
aortic
constrict
condit
suggest
may
protect
heart
failur
progress
heartspecif
transgen
overexpress
wildtyp
mice
result
compensatori
increas
level
henc
associ
mild
heart
dysfunct
third
heartspecif
express
transgen
encod
human
bind
mutant
mice
also
result
higher
activ
impair
heart
function
increas
arrhythmia
fourth
heartspecif
transgen
express
constitut
inhibitori
fragment
ctermin
truncat
form
mice
show
enhanc
cardiac
contractil
associ
sever
decreas
activ
increas
phosphoryl
pln
serin
despit
increas
level
importantli
heartspecif
transgen
express
express
mice
rescu
phenotyp
show
normal
activ
heart
morpholog
heart
function
although
transgen
express
act
similarli
heart
base
reduc
pln
phosphoryl
global
ko
embryon
lethal
suggest
distinct
function
tissu
fifth
global
ko
homolog
associ
decreas
blood
pressur
abnorm
heart
morpholog
respect
tabl
decreas
blood
pressur
also
observ
mice
express
nonphosphorylat
mutant
act
constitut
inact
inhibitor
confirm
import
interact
phenotyp
sixth
heartspecif
transgen
express
cardioprotect
associ
increas
phosphoryl
pln
serin
threonin
enhanc
sarcoplasm
reticulum
calcium
cycl
elev
level
also
improv
cardiac
function
angiogenesi
diabet
mice
togeth
differ
mous
model
suggest
inhibit
hold
great
potenti
treatment
heart
failur
howev
approach
consid
cautious
first
longterm
inhibit
worsen
heart
failur
condit
pressur
overload
ie
experiment
model
cardiac
hypertrophi
second
ablat
cardioprotect
condit
increas
adrenerg
drive
third
induc
heartspecif
express
mice
improv
heart
function
young
mice
deleteri
catecholaminerg
stress
increas
age
thu
still
uncertain
whether
benefici
detriment
develop
heart
diseas
four
ipip
kepi
associ
neurolog
phenotyp
tabl
induc
express
constitut
activ
inhibitor
brain
improv
learn
memori
impair
recoveri
ischem
stroke
thu
constrain
learn
memori
format
posit
regul
recoveri
brain
damag
homolog
highli
enrich
dopaminocept
medium
spini
neuron
striatum
turn
potent
inhibitor
upon
phosphoryl
eg
protein
kinas
play
pivot
role
variou
neurolog
process
includ
dopamin
neurotransmiss
medium
spini
neuron
classifi
striatonigr
striatopallid
neuron
morpholog
similar
differ
express
differ
subtyp
dopamin
receptor
striatonigr
neuron
primarili
express
dopamin
receptor
type
striatopallid
neuron
primarili
express
dopamin
receptor
type
variou
neurolog
psychiatr
disord
drug
addict
schizophrenia
parkinson
diseas
character
disturb
balanc
signal
often
associ
alter
function
global
delet
mice
led
alter
dopaminerg
neurotransmiss
impair
behavior
respons
psychostimul
eg
cocain
antipsychot
drug
eg
haloperidol
cell
typespecif
delet
express
differentiallytag
neuron
mice
reveal
neuronspecif
pathway
brain
coupl
opposit
function
output
psychostimul
antipsychot
drug
exert
differenti
effect
phosphoryl
striatonigr
striatopallid
neuron
explain
oppos
behaviour
clinic
effect
mice
carri
mutat
endogen
gene
thu
express
constitut
inact
inhibitor
larg
phenocopi
ko
function
biochem
exampl
mice
mice
specif
ablat
striatonigr
neuron
featur
phosphosubstr
alter
tabl
underscor
import
holoenzym
observ
phenotyp
genet
delet
allel
embryon
lethal
heterozyg
mice
exhibit
overt
phenotyp
show
increas
memori
format
decreas
activ
increas
importantli
model
show
despit
presum
function
inhibitor
posit
regul
memori
function
vivo
kepi
yet
anoth
ipip
link
neurolog
phenotyp
kepi
inhibit
phosphoryl
protein
kinas
c
global
delet
kepi
associ
increas
activ
decreas
respons
morphin
chronic
morphin
inject
suggest
select
inhibit
enhanc
morphin
analgesia
collect
neurolog
phenotyp
associ
differ
ipip
reveal
constrain
learn
memori
format
play
key
role
dopamin
neurotransmiss
morphin
signal
therefor
target
particular
ipip
holoenzym
valuabl
therapeut
approach
treatment
variou
neurolog
disord
howev
cell
typeselect
method
may
requir
target
exampl
global
ko
kepi
disclos
import
ipip
treatment
viral
infect
tabl
kepinul
mice
suscept
pathogenesi
sever
acut
respiratori
syndrom
coronaviru
sarscov
suggest
kepi
may
protect
viru
independ
studi
identifi
import
type
viral
infect
includ
human
immunodefici
viru
hiv
hepat
b
adenoassoci
viru
howev
find
yet
valid
mous
model
coupl
pip
transactiv
transcript
tat
hepat
b
regulatori
protein
x
hbx
nuclear
inhibitor
respect
mous
model
guid
pip
divers
gpip
gpip
employ
variou
strategi
guid
subset
substrat
fig
mani
gpip
contain
subcellulartarget
domain
bind
specif
organel
macromolecular
complex
glycogen
particl
plasma
membran
endoplasm
reticulum
exampl
variou
glycogentarget
g
subunit
eg
hepat
glycogentarget
protein
phosphatas
regulatori
subunit
gl
skelet
muscl
glycogentarget
protein
phosphatas
regulatori
subunit
gm
protein
target
glycogen
ptg
target
toward
glycogen
therebi
enhanc
dephosphoryl
glycogenassoci
substrat
glycogen
synthas
glycogen
phosphorylas
gpip
substraterecruit
domain
bind
specif
subset
substrat
exampl
forkheadassoci
domain
bind
specif
subset
protein
phosphoryl
threonineprolin
dipeptid
motif
regul
dephosphoryl
associ
one
pip
alon
combin
multipl
subcellulartarget
andor
substraterecruit
domain
exampl
gm
separ
glycogen
membranetarget
domain
fig
stressinduc
protein
bind
endoplasm
reticulum
via
subcellulartarget
substraterecruit
domain
respect
variou
gpip
number
isoform
often
differ
tissu
express
pattern
exampl
mammalian
genom
harbor
seven
gene
encod
isoform
glycogentarget
g
subunit
gene
encod
gm
gl
ptg
isoform
respect
gm
primarili
express
muscl
gl
liver
ptg
ubiquit
express
tg
lacz
tg
nuclear
activ
improv
memori
perform
enhanc
longterm
potenti
alter
gene
transcript
neurabin
abnorm
psychostimul
respons
dopamin
signal
transduct
reduc
anxietyand
depressionrel
behavior
young
adult
mice
impair
contextu
fear
memori
abnorm
psychostimul
respons
dopamin
signal
transduct
reduc
brain
size
reduc
anxietyand
depressionrel
behavior
middleag
mice
associ
learn
abil
actin
aortic
smooth
muscl
alb
albumin
growth
arrest
dna
damageinduc
transcript
calciumcalmodulindepend
protein
kinas
type
ii
subunit
alpha
ckm
creatin
kinas
muscl
cre
site
specif
recombinas
crep
constitut
repressor
phosphoryl
transcript
factor
eukaryot
translat
initi
factor
eiia
adenoviru
promot
direct
cre
express
preimplant
embryo
glutam
ionotrop
receptor
ampa
type
subunit
gs
glycogen
synthas
muscl
isoform
liver
isoform
gl
hepat
glycogentarget
protein
phosphatas
regulatori
subunit
gm
skelet
muscl
glycogentarget
protein
phosphatas
regulatori
subunit
gp
glycogen
phosphorylas
muscl
isoform
pygm
liver
isoform
pygl
ko
knockout
lacz
betagalactosidas
cardiac
muscl
alpha
isoform
myosin
heavi
chain
smooth
muscl
isoform
myosin
heavi
chain
rlc
cardiac
ventricular
myosin
regulatori
myosin
light
chain
nd
determin
p
phospho
rb
retinoblastoma
sr
sarcoplasm
reticulum
tg
transgen
thapsigargindtt
induc
er
stress
induc
hemininduc
kclnorepinephrinecarbacholinduc
contract
dopamin
agonistinduc
number
phosphoamino
acid
correspond
mous
sequenc
accord
http
wwwphosphositeorg
identifi
gpipencod
gene
b
function
studi
use
genet
modifi
mous
model
show
phenotyp
tabl
mous
model
show
alter
activ
andor
alter
phosphoryl
level
substrat
six
gpip
gm
gl
crep
least
one
mous
model
express
pip
mutant
alter
associ
function
phenotyp
analys
express
mutant
mice
enabl
identif
interact
site
huge
therapeut
potenti
select
six
gpip
review
gmand
gldefici
mice
show
increas
phosphoryl
substrat
glycogen
synthas
glycogen
phosphorylas
result
inactiv
glycogen
synthas
activ
glycogen
phosphorylas
thu
decreas
glycogen
content
tabl
furthermor
striatedmuscl
specif
transgen
express
gm
associ
increas
muscl
glycogen
content
abolit
glycogen
synthas
activ
respons
exercis
tabl
third
gm
mous
model
express
ctermin
truncat
form
gm
gm
intact
glycogentarget
domain
lack
sarcoplasmictarget
domain
fig
mice
demonstr
impair
glycogen
synthesi
associ
inactiv
glycogen
synthas
ie
hyperphosphoryl
thu
phenocopi
gmnull
mice
tabl
result
suggest
disturb
bind
gpip
subcellular
structur
lead
nonfunct
holoenzym
therefor
interfer
subcellular
target
gpip
potenti
therapeut
target
alter
function
fig
tabl
interestingli
phenylalanin
mutat
gl
tyrosin
prevent
alloster
inhibitori
bind
phosphoglycogenphosphorylas
gl
result
dephosphoryl
activ
glycogen
synthas
thu
knockin
mice
express
mutant
gl
display
enhanc
hepat
glycogen
synthas
activ
improv
glucos
toler
support
notion
pharmacolog
inhibit
particular
gl
phosphoglycogenphosphorylas
interact
use
combat
diabet
hyperglycaemia
encod
gene
major
nuclear
pip
ubiquit
express
express
level
celltyp
depend
ntermin
forkheadassoci
domain
recruit
substrat
phosphoryl
threonineprolin
dipeptid
motif
includ
premrna
splice
factor
methyltransferas
bind
via
central
ctermin
domain
global
delet
mice
result
earli
embryon
lethal
associ
reduc
cell
prolifer
tabl
similarli
postnat
tamoxifeninduc
delet
testi
result
progress
loss
germ
cell
culmin
sertolicellonli
phenotyp
attribut
decreas
prolifer
surviv
capac
cell
spermatogen
lineag
contrast
liverspecif
ko
show
rather
mild
phenotyp
associ
bileduct
hyperplasia
enhanc
biliari
epitheli
cell
prolifer
collect
mous
model
indic
function
may
celltyp
depend
embryo
embryon
day
show
increas
global
phosphothreonin
signal
line
substratespecifi
role
tabl
data
avail
regard
alter
activ
andor
substrat
phosphoryl
induc
condit
ko
howev
variou
biochem
cellular
assay
reveal
known
cellular
function
premrna
splice
transcript
larg
depend
associ
recruit
substrat
mice
induc
express
central
part
forebrain
show
decreas
nuclear
activ
increas
histon
phosphoryl
serin
tabl
sinc
mainli
compris
central
domain
includ
substraterecruit
domain
seem
like
effect
stem
titrat
effect
result
competit
disrupt
pip
holoenzym
import
forebrain
transgen
mice
demonstr
improv
longterm
memori
associ
decreas
nuclear
activ
agreement
phenotyp
observ
transgen
mice
express
constitut
inhibitori
mutant
tabl
likewis
decreas
detect
mice
express
inact
mutant
tabl
gene
encod
growtharrest
dnadamageinduc
transcript
constitut
repressor
phosphoryl
crep
respect
target
eukaryot
initi
factor
eif
dephosphoryl
phosphoserin
associ
phosphoserin
mous
correspond
wellknown
phosphoserin
site
crep
share
structur
homolog
ctermini
harbor
domain
express
mainli
induc
stress
condit
crep
constitut
express
level
unchang
stress
stress
signal
eukaryot
cell
depend
critic
phosphoryl
serin
occur
exampl
respons
accumul
misfold
protein
endoplasm
reticulum
also
known
unfold
protein
respons
upr
amino
acid
depriv
viral
infect
upon
stress
get
hyperphosphoryl
serin
attenu
global
protein
synthesi
induc
express
crep
transcript
protein
level
express
gener
feedback
loop
revers
stressinduc
phosphoryl
therebi
restor
normal
protein
synthesi
thu
basal
condit
dephosphoryl
tightli
regul
crep
respons
dephosphoryl
stress
condit
mice
lack
either
crep
exhibit
enhanc
basal
andor
stressinduc
signal
indic
isoform
crucial
dephosphoryl
serin
tabl
two
genet
engin
mice
model
confirm
increas
stressinduc
hyperphosphoryl
serin
tabl
first
condit
ko
model
ablat
earli
embryon
stage
use
creloxp
system
confirm
alter
phosphoryl
second
mice
express
truncat
form
longer
abl
form
function
phosphatas
complex
still
interact
display
similar
effect
latter
mous
model
establish
import
interact
dephoshoryl
phenotyp
mice
lack
function
exhibit
mild
phenotyp
visibl
abnorm
demonstr
enhanc
obes
fed
highfat
diet
impair
hepatocarcinogenesi
chemicallyinduc
tumorigenesi
model
erythrocyt
defect
resembl
mild
thalassemia
syndrom
contrast
global
delet
crep
caus
perinat
lethal
associ
sever
anemia
furthermor
mice
express
lack
crep
display
earli
embryon
lethal
demonstr
crep
overlap
well
distinct
function
togeth
suggest
function
redund
two
isoform
embryon
develop
throughout
neonat
stage
importantli
earli
embryon
lethal
could
rescu
alanin
mutat
serin
indic
import
substrat
crep
virus
encod
protein
eg
structur
relat
ctermin
domain
also
promot
dephosphoryl
enabl
virus
revers
translat
block
instig
enter
host
cell
final
evid
biochem
level
exist
trimer
complex
actin
hint
addit
level
regul
phosphatas
gain
insight
physiolog
import
dephosphoryl
would
worthwhil
analyz
stressinduc
phosphoryl
mice
therapeut
perspect
drug
maintain
phosphoryl
inhibit
phosphatas
hold
great
promis
treatment
protein
misfold
disord
eg
neurodegen
diseas
viral
infect
famili
phosphatas
actin
regul
phactr
compris
four
structur
relat
member
isoform
exhibit
differ
spatiotempor
express
pattern
brain
mice
contain
highli
conserv
ctermin
domain
preced
actintarget
domain
mice
missens
mutat
gene
known
humdi
express
mutant
bind
actin
tabl
indic
phenotyp
humdi
caus
defici
target
humdi
mutant
mous
embryo
defect
neural
tube
optic
fissur
closur
result
exencephali
fetal
malform
protrud
brain
tissu
retin
coloboma
eye
abnorm
fetal
neural
phenotyp
accord
specif
express
neural
stem
cell
develop
adult
mous
brain
phenotyp
rescu
loss
transcript
factor
indic
regul
cell
cycl
progress
neurul
eye
develop
molecular
level
disrupt
interact
led
increas
inhibitori
phosphoryl
threonin
result
retinoblastoma
rb
hyperphosphoryl
derepress
target
humdi
phenotyp
also
seem
mimic
hirschsprung
diseas
human
congenit
disord
distal
colon
character
absenc
enter
nervou
system
inde
humdi
mutant
show
intestin
hypoganglionosi
reduc
number
nerv
intestin
wall
well
defect
cell
migrat
lamellipodia
enter
neural
crest
cell
suggest
holoenzym
play
role
direct
migrat
enter
neural
crest
cell
lastli
screen
mous
model
connect
pipencod
gene
associ
human
diseas
first
examin
piprel
mous
model
fig
classif
pip
accord
biolog
function
connect
least
one
human
diseaseassoci
phenotyp
figur
show
isoform
pip
link
specif
patholog
reminisc
sever
human
diseas
cardiovascular
system
heart
failur
heart
arrhythmia
andor
hypertens
behaviouralneurolog
drug
addict
schizophrenia
andor
parkinson
diseas
homeostaticmetabol
type
diabet
andor
bile
duct
hyperplasia
reproduct
male
infertil
haematolog
thalassemia
respiratori
system
sarscov
pathogenesi
see
text
refer
protein
phosphatas
pip
interact
protein
sarscov
sever
acut
respiratori
syndrom
coronaviru
function
link
ipip
gpip
tabl
human
diseaseassoci
phenotyp
annot
base
mous
genom
informat
databas
http
wwwinformaticsjax
org
well
scientif
literatur
fig
categor
pip
protein
accord
biolog
function
connect
least
one
human
diseas
cardiovascular
heart
failur
heart
arrhythmia
hypertens
behaviouralneurolog
drug
addict
schizophrenia
parkinson
diseas
human
hirschsprung
diseas
homeostasicmetabol
type
diabet
bile
duct
hyperplasia
reproduct
male
infertil
haematolog
thalassemia
respiratori
system
sarscov
pathogenesi
mortal
muscl
system
fig
next
screen
mous
model
pip
connect
human
diseas
use
mous
genom
informat
databas
found
pip
affili
human
diseaseassoci
phenotyp
connect
eight
differ
diseas
area
cardiovascular
behaviouralneurolog
homeostasismetabol
reproduct
haematolog
renal
immun
system
muscl
cancer
predisposit
disord
document
tabl
pip
associ
two
human
diseas
area
although
pip
biochem
proven
interactor
phenotyp
yet
connect
function
indic
exclud
molecular
basi
human
diseas
phenotyp
none
mous
model
function
link
tabl
display
spontan
cancer
phenotyp
although
variou
pip
complex
link
cell
cycl
progress
cancer
howev
mous
model
five
nonfunct
valid
pip
tumor
suppressor
apc
rb
protein
kinas
aurora
chromatin
remodel
factor
connect
cancer
predisposit
tabl
variou
genet
engin
mous
model
pip
show
increas
suscept
develop
tumor
hint
opportun
target
pip
complex
also
cancer
therapi
sinc
bind
site
pip
map
connect
explor
structur
revers
genet
ie
genet
engin
mous
model
express
pip
mutant
alter
associ
function
affect
interact
ligand
mutant
gener
delet
domain
eg
introduct
point
mutat
domain
eg
noninhibitori
eg
constitutivelyinhibitori
mutant
eg
gener
mutat
critic
residu
domain
gener
mutant
mice
endors
function
involv
particular
mous
phenotyp
tabl
importantli
interact
within
function
holoenzym
complex
interact
pip
subcellular
structur
also
exploit
target
therapeut
intervent
exampl
gm
mutant
togeth
recent
expans
structur
biolog
method
genom
edit
technolog
expect
structur
revers
genet
increas
popular
lead
identif
holoenzym
therapeut
potenti
exist
alon
mammalian
cell
alway
associ
least
one
ipip
gpip
gener
numer
distinct
multisubunit
complex
dephosphoryl
small
set
substrat
divers
holoenzym
increas
differ
isoform
ipip
eg
gpip
eg
seven
isoform
glycogentarget
g
subunit
isoform
deriv
distinct
gene
result
gene
duplic
evolut
isoform
structur
relat
often
differ
spatiotempor
express
pattern
gm
gl
instanc
overlap
distinct
function
eg
crep
examin
mice
connect
pipencod
gene
reveal
diseaseassoci
phenotyp
protein
depend
function
tabl
fig
other
yet
function
link
tabl
propos
use
structur
revers
genet
combin
structur
character
protein
mous
genet
power
attract
tool
establish
whether
humandiseaseassoci
phenotyp
physiolog
depend
function
variou
interact
site
includ
pip
substrat
subcellular
interact
site
consid
therapeut
target
see
color
circl
fig
believ
structur
revers
genet
provid
excit
opportun
new
discoveri
initi
step
identifi
novel
therapeut
target
conclus
mice
model
contribut
enorm
understand
vivo
function
holoenzym
confirm
pleiotrop
role
health
diseas
especi
heart
brain
discoveri
least
pip
protein
associ
human
diseaseassoci
phenotyp
suggest
huge
potenti
target
holoenzym
indic
pipdirect
drug
hold
great
potenti
treatment
human
diseas
author
declar
conflict
interest
work
support
flemish
concert
research
action
goa
transpar
document
associ
articl
found
onlin
version
